• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Biogen’s Alzheimer’s hopeful aducanumab faces ‘less than a coin flip’s chance’ of FDA approval: anal





Are we even surprised? B Dunn has been tremendously biased from the start which looks terrible on the FDA in terms of fair and balanced objectivity. FDA reaches out to Media prior to advisory board? Insane.

What many employees are now realizing is that even if it were approved against all odds, the restrictions would be suffocating and the processes to work through would be migraine after migraine, making the job intolerable.

If Biogen was truly confident in this product, then spend the money and do a second phase 3 trial. I have heard Biogen won't even do that if the FDA makes that request. So that tells the world their lack of confidence in the product.
 












That’s a wrap folks. Carry on with your Awesome lives!

Exactly! Why cry about it? I think it gave me great experience to a new disease state and will help me with future endeavors. This isn't going to happen. Can we say C.O.N.T.R.O.V.E.R.S.I.A.L? Never have seen so many problems and issues with any other drug. Like an earlier comment, I agree the job wouldn't be very fun or rewarding with such a narrow indication and every single day would be piles of fires to put out. So if that would be the case, I would rather move on. At first, I was surprised hearing rumors on how many DAAL's, AAL's and TBM's have been interviewing, but not anymore. I'm not ready to start interviewing, but don't blame those that do.
 












Exactly! Why cry about it? I think it gave me great experience to a new disease state and will help me with future endeavors. This isn't going to happen. Can we say C.O.N.T.R.O.V.E.R.S.I.A.L? Never have seen so many problems and issues with any other drug. Like an earlier comment, I agree the job wouldn't be very fun or rewarding with such a narrow indication and every single day would be piles of fires to put out. So if that would be the case, I would rather move on. At first, I was surprised hearing rumors on how many DAAL's, AAL's and TBM's have been interviewing, but not anymore. I'm not ready to start interviewing, but don't blame those that do.

great experience doing what? Profiling accounts, doing busy work, etc? How much did you sell and just how successful have you been? Sorry it isn’t going to work out but don’t delude yourself into thinking your resume looks stronger because you can list Biogen on it
 




great experience doing what? Profiling accounts, doing busy work, etc? How much did you sell and just how successful have you been? Sorry it isn’t going to work out but don’t delude yourself into thinking your resume looks stronger because you can list Biogen on it

Adu rep = poor judgment and rusty.
 








great experience doing what? Profiling accounts, doing busy work, etc? How much did you sell and just how successful have you been? Sorry it isn’t going to work out but don’t delude yourself into thinking your resume looks stronger because you can list Biogen on it

omg stop feeling so threatened. Any idiot knows it will help adu reps have ms on their resumes. This will get them through phase one and any automatic screenings looking for MS on resume. Once they secure an interview they can rock it and get passed any initial hiring biases. Okay the ms reps don't like it. Tough cookies.
 




great experience doing what? Profiling accounts, doing busy work, etc? How much did you sell and just how successful have you been? Sorry it isn’t going to work out but don’t delude yourself into thinking your resume looks stronger because you can list Biogen on it

Damn straight. Biogen no longer means anything more than big pharma exp on a resume.